add_icon

Concord Biotech

1,228.60
-2.30
(-0.19%)
Market Cap
12,853.15 Cr
PE Ratio
40.98
Volume
29,81,754.00
Day High - Low
1,285.00 - 1,195.50
52W High-Low
2,150.40 - 1,068.60
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
12,853.15 Cr
EPS
35.52
PE Ratio
40.98
PB Ratio
6.98
Book Value
174.68
EBITDA
550.80
Dividend Yield
0.72 %
Industry
Healthcare
Return on Equity
20.50
Debt to Equity
0.00
Forecast For
Actual

Company News

View All News
Caret
positive
Concord Biotech reports steady Q3 FY26 performance with revenues of ₹278 crores, marking 14% YoY growth. Injectable facility receives WHO GMP certification while company addresses earlier H1 challenges.
neutral
Concord Biotech responds to BSE inquiry about increased trading volume, confirming compliance with disclosure norms and stating no undisclosed price-sensitive information pending announcement.
neutral
Hina Patel, Company Secretary and Compliance Officer at Concord Biotech Limited, has tendered her resignation to pursue opportunities outside the organization, effective January 21, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,778.90
#1 4,26,817.70
38.64
#1 54,729.00
9.71
#1 10,980
16.07
66.93
6,419.50
1,70,417.55
68.52
9,712.00
18.67
2,191
-1.02
58.33
4,419.50
1,49,575.96
65.84
11,539.40
6.99
1,911
26.24
75.24
1,310.60
1,09,386.65
19.75
33,741.20
16.73
5,725
-15.28
64.85
1,349.50
1,09,008.80
23.98
28,409.50
7.12
5,291
-57.18
46.84
2,313.90
1,05,698.68
22.44
22,909.50
13.74
3,306
#1 37.44
69.01
932.50
93,831.32
#1 18.41
23,511.00
18.55
4,615
-0.32
56.15
2,246.30
92,728.40
49.34
12,744.20
#1 20.90
2,007
7.65
57.55
1,232.00
71,554.76
20.23
32,345.60
9.43
3,484
7.59
57.08
5,673.00
67,829.22
27.73
13,458.30
3.70
2,216
1.90
51.41

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
18.44 %
Net Income Growth
20.61 %
Cash Flow Change
-7.89 %
ROE
1.59 %
ROCE
0.49 %
EBITDA Margin (Avg.)
-0.07 %

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
22 Jun 2024 DIVIDEND Dividend
8.75 /share
21 Jun 2024 1,460.10 1,559.25
29 Jun 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Jun 2024 1,460.10 1,549.05
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 1,812.25 1,850.00
13 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Feb 2025 2,125.70 2,119.00
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 1,532.10 1,635.70
08 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Aug 2025 1,739.70 1,633.10
03 Sept 2025 DIVIDEND Dividend
10.70 /share
03 Sept 2025 1,635.70 1,691.15
09 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
09 Sept 2025 1,648.30 1,610.20
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 1,394.90 1,462.85
11 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2026 1,168.20 1,283.50

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.20%
444
-0.02%
-0.03%
DSP Nifty 500 Index Fund Direct-Growth
0.02%
20
0.02%
0.02%
DSP Nifty Smallcap 250 Index Fund Direct - Growth
0.20%
19
-0.02%
0.20%
Navi Nifty MidSmallcap 400 Index Fund Direct - Growth
0.07%
3
-0.01%
0.07%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.02%
2
0.00%
0.00%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.20%
0
0.00%
-0.02%
HSBC Small Cap Fund Direct-Growth
0.46%
0
0.00%
-0.04%
Bajaj Finserv Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.31%
0
0.00%
-0.02%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.05%
0
0.00%
-0.01%
Bandhan Midcap Fund Direct-Growth
0.00%
0
0.00%
-0.23%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.21%
0
0.00%
-0.01%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Baroda BNP Paribas Balanced Advantage Fund Direct - Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Business Cycle Fund Direct - Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Children's Fund Direct-Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Conservative Hybrid Fund Direct-Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas ELSS Tax Saver Fund Direct-Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Equity Savings Fund Direct - Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Innovation Fund Direct - Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Large & Mid Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Multi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Retirement Fund Direct - Growth
0.00%
0
0.00%
0.00%
Canara Robeco Manufacturing Fund Direct - Growth
0.51%
0
0.00%
-0.05%

Technical Indicators

RSI(14)
Neutral
53.48
ATR(14)
Volatile
63.12
STOCH(9,6)
Oversold
16.30
STOCH RSI(14)
Neutral
27.27
MACD(12,26)
Bullish
0.65
ADX(14)
Weak Trend
23.24
UO(9)
Bearish
48.78
ROC(12)
Downtrend But Slowing Down
-3.25
WillR(14)
Neutral
-48.70

About Concord Biotech

Concord Biotech Limited is an India-based biopharma company that develops and manufactures fermentation-based APIs and formulations. It focuses on immunosuppressants, oncology, anti-infectives, nephrology, and critical care. The company operates three manufacturing facilities in Gujarat, India, with a total annual installed fermentation capacity of 1,250 m3 for APIs. Concord Biotech supplies...more
Listing Date
18 Aug, 2023(2 Years, 39 days)
Chairperson NameSUDHIR JAIRAM VAID